Metabolic effects of intramuscular and oral administration of ritodrine in pregnancy

P. Schreyer, E. Caspl*, E. Snir, E. Herzianu, P. User, Y. Gilboa, J. L. Zaidman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The metabolic effects of ritodrine, 80 mg/day, administered intramuscularly in the third trimester of pregnancy to 14 patients for 5 days and per os to 10 patients for 10 days were investigated. Each patient was considered at high risk for premature labor. Intravenous glucose tolerance and insulin, triglyceride, and electrolyte levels were assessed before and at the end of treatment with ritodrine. Intramuscularly or orally administered ritodrine in 10-mg doses 8 times a day did not influence carbohydrate homeostasis. Triglyceride levels fell significantly after intramuscular administration, Whereas serum potassium levels increased during treatment. This study suggests that ritodrine administered intramuscularly or orally is metabolically safe in nondiabetic pregrlant women.

Original languageEnglish
Pages (from-to)730-733
Number of pages4
JournalObstetrics and Gynecology
Issue number6
StatePublished - Jun 1981
Externally publishedYes


Dive into the research topics of 'Metabolic effects of intramuscular and oral administration of ritodrine in pregnancy'. Together they form a unique fingerprint.

Cite this